About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Cardiac Failure
›
Top Articles
Journal of Cardiac Failure
3.3
(top 14%)
Impact Factor
3.6
(top 14%)
extended IF
115
(top 3%)
H-Index
2.3K
authors
3.5K
papers
85.1K
citations
4.9K
citing journals
34.2K
citing authors
Most Cited Articles of Journal of Cardiac Failure
Title
Year
Citations
HFSA 2010 Comprehensive Heart Failure Practice Guideline
2010
929
High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database
2007
560
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
2006
518
The prognostic importance of different definitions of worsening renal function in congestive heart failure
2002
454
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis
2007
444
Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline
2006
393
Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline
2009
388
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group
1999
380
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017
378
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study
2001
341
Basic mechanisms in heart failure: the cytokine hypothesis
1996
338
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial
2009
331
Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure
2001
316
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
1997
290
Consensus statement: Palliative and supportive care in advanced heart failure
2004
284
Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?
2003
279
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure
2010
272
Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure
2002
261
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
1999
261
Risk stratification after hospitalization for decompensated heart failure
2004
257
Psychometric testing of the self-care of heart failure index
2004
255
Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators
2000
250
The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure
2005
245
HFSA 2006 Comprehensive Heart Failure Practice Guideline
2006
241
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity
2003
239
previous
2005
2006
2007
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.